¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"uniform rate hypothesis"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
¿µ¹® basal metabolic rate(BMR) ÇÑ±Û ±âÃÊ´ë»çÀ²
¼³¸í   
  Ç¥ÁØ ±âÃÊ´ë»ç·®°ú ºñ±³ÇßÀ» ¶§ °³Ã¼ ±âÃÊ´ë»ç·®ÀÌ º¸À̴ ÆíÂ÷¸¦ Ç¥½ÃÇϴ Áö¼ö. ±âÃÊ´ë»ç·®Àº »ý¸íÀ» À¯ÁöÇϴµ¥ ÇÊ¿äÇÑ ÃÖ¼ÒÇÑÀÇ ¿¡³ÊÁö ´ë»ç·®À̸ç, ¼º°ú ¿¬·ÉÀÌ µ¿ÀÏÇÑ °Ç°­ÀÎÀÇ ±âÃÊ´ë»ç·®Àº Ã¼Ç¥¸éÀû¿¡ ºñ·ÊÇÑ´Ù. À̰ÍÀ» Ã¼Ç¥¸éÀûÀÇ ¹ýÄ¢À̶ó°í Çϸç, 1882³â µ¶ÀÏÀÇ ´ë»ç»ý¸®ÇÐÀÚ M. ºê·ç³Ê¿¡ ÀÇÇØ Á¦Ã¢µÇ¾ú´Ù. Ã¼Ç¥¸éÀûÀº ½ÅÀå°ú Ã¼Áß¿¡ ÀÇÇØ »êÃâµÈ´Ù. µû¶ó¼­ ¼º-¿¬·É-½ÅÀå-üÁßÀ» ¾Ë¸é Ç¥ÁرâÃÊ·® Y°¡ »êÃâµÇ°í ½ÇÁ¦ÀÇ ±âÃÊ´ë»ç·® X´Â »ê¼Ò¼Òºñ·®°ú ÀÌ»êȭź¼Ò ¹ß»ý·®¿¡¼­ »êÃâµÈ´Ù. ±×¸®°í X¿Í YÀÇ Â÷À̸¦ Y·Î ³ª´« °ª(%)À» ±âÃÊ´ë»çÀ²À̶ó°í ÇÑ´Ù. °æÇèÀûÀ¸·Î ¾òÀº BMRÀÇ °£´ÜÇÑ ÃøÁ¤¹ýµµ ÀÖÀ¸¸ç ´ÙÀ½°ú °°Àº ½ÄÀ¸·Î ±¸ÇÑ´Ù. ÀÌ ½Ä¿¡¼­ ¸ÆÆøÀ̶õ ÃÖ°íÇ÷¾Ð°ú ÃÖÀúÇ÷¾ÐÀÇ Â÷¸¦ ¸»ÇÑ´Ù. BMR(%)=0.75(1ºÐ ¸Æ¹Ú¼ö + 0.74¡¿¸ÆÆø)£­72. BMRÀÌ 10% À̳»À̸é Á¤»ó¹üÀ§, +10% ÀÌ»óÀ̸頱âÃÊ´ë»çÇ×Áø, £­10% ÀÌÇÏÀ̸頱âÃÊ´ë»ç ÀúÇ϶ó°í ÇÑ´Ù. ±âÃÊ´ë»ç´Â °øº¹½Ã(½ÄÈÄ 10½Ã°£ °æ°ú)¿¡ ¾ÈÁ¤µÈ »óÅ¿¡¼­ ´ÜÀ§ ½Ã°£´ç ÀÌ¿ëµÇ´Â ¿¡³ÊÁöÀÇ ¾ç, Áï, ÇÑ ½Ã°£´ç, ¸ö Ç¥¸éÀÇ 1m2´ç ¶Ç´Â ¸ö¹«°Ô 1kg ´ç Ä®·Î¸®·Î ³ªÅ¸³½´Ù. À̰ÍÀº °³Àο¡ µû¶ó ´Ù¸£¸ç Àå±â°£¿¡´Â °ÅÀÇ º¯È­°¡ ¾øÁö¸¸ Áúº´ µîÀ¸·Î ÀÎÇØ º¯µ¿µÈ´Ù. ½ÇÃøÇÑ ±âÃÊ´ë»ç¸¦ Ç¥ÁØÄ¡¿Í ºñ±³ÇÔÀ¸·Î½á Áúº´ÀÇ Áø´Ü µî¿¡ ÀÀ¿ëÇÒ ¼ö ÀÖ´Ù BMR=(½ÇÃøÄ¡-Ç¥ÁØÄ¡)/Ç¥ÁØÄ¡ ¡¿100(%)·Î ³ªÅ¸³½´Ù.
¿µ¹® five-year survival rate ÇÑ±Û ¿À³â»ýÁ¸À²
¼³¸í   
  1. µ¿ÀÏ Áúº´ÀÇ Áø´Ü È¤Àº Ä¡·á ÈÄ, 5³âÀÌ °æ°ú µÈ µÚÀÇ »ýÁ¸ÀÚ¼öÀǠǥÇö. 2. ¾ÏÀÇ Áø´Ü ¶Ç´Â Ä¡·á µÚ¿¡ °Ë»ç¸¦ ¹Ýº¹ÇÏ¿© 5³â µ¿¾È »ì¾Æ Àִ »ç¶÷ÀÇ ¹éºÐÀ². Ä¡·á ÈÄ 5³â µ¿¾È »ýÁ¸Çϸé ÀÏ´Ü Ä¡À¯µÈ °ÍÀ¸·Î °£ÁÖÇÑ´Ù.
¿µ¹® ESR(Erythrocyte Sedimentation Rate) ÇÑ±Û ÀûÇ÷±¸Ä§°­¼Óµµ, Ç÷ħ
¼³¸í   
  Ç÷¾×ÀÌ ÀÀ°íµÇ´Â °ÍÀ» ¹æÁöÇϴ Ç×ÀÀ°íÁ¦¸¦ ³ÖÀº Ç÷¾×À» Ä§°­¿ë À¯¸®°ü¿¡ ³Ö¾î °¡¸¸È÷ ¼¼¿ö µÎ¾úÀ» ¶§ ÀûÇ÷±¸°¡ °¡¶ó¾É´Â ¼Óµµ¸¦ À̸£´Â ¸»ÀÌ´Ù. 1918³â ½º¿þµ§ÀÇ º´¸®ÇÐÀÚ ÆÄ·¹¿ì½ºÀǠâ¾È¿¡ ÀÇÇÑ °ÍÀÌ´Ù. ÃøÁ¤¹æ¹ýÀ¸·Î ¿©·¯ °¡Áö°¡ Àִµ¥, ±¹Á¦Ç¥ÁعýÀ¸·Î´Â 1973³â ¿þ½ºÅͱ׷»¹ýÀÇ 1½Ã°£¹ýÀÌ ¼±Á¤µÇ¾úÀ¸¸ç, 1977³â ±×°ÍÀ» °³Á¤ÇÏ¿© °¢±¹¿¡¼­ ¾²µµ·Ï ±ÇÀåÇϰí ÀÖ´Ù. 1½Ã°£ ÈĠħ°­¿ë À¯¸®°ü À§ÂÊÀÇ Ç÷Àå±âµÕÀÇ ³ôÀ̸¦ mm·Î Àоî, ±×°ÍÀ» ÀûÇ÷±¸Ä§°­ÀÇ 1½Ã°£°ªÀ¸·Î ÇÑ´Ù. ¸¸¾à Ç÷Àå°ú ÀûÇ÷±¸ÀÇ °æ°è°¡ ¼±¸íÇÏÁö ¸øÇÑ °æ¿ì, ÀûÇ÷±¸ÀÇ ¹Ðµµ°¡ ±× ÀÌÇÏ¿¡¼­´Â ÀÏÁ¤ÇÏ´Ù°í ¿©°ÜÁö´Â °÷ÀÇ ´«±ÝÀ» Àоî ÀûÇ÷±¸Ä§°­ÀÇ 1½Ã°£°ªÀ¸·Î ÇÑ´Ù. ÃøÁ¤ ¶§ÀÇ ½Ç³»¿Âµµ´Â 18~25µµ·Î ÇÑ´Ù. ÀϹÝÀûÀ¸·Î À̺¸´Ù ¿Âµµ°¡ ³ôÀº °æ¿ì´Â Ç÷ħ¹ÝÀÀÀÌ ÃËÁøµÇ¸ç, ³·Àº °æ¿ì´Â ´Ê¾îÁø´Ù. Á¤»ó °ªÀº 2~10mm(³²ÀÚ), 3~15mm(¿©ÀÚ)À̸ç 15¼¼ ÀÌÇÏÀÇ ¾î¸°ÀÌ, 50¼¼ ÀÌ»óÀÇ °í·ÉÀÚ¿¡¼­´Â ¾à°£ ³ô´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • uniform circular motion
    µî¼Ó¿ø¿îµ¿
  • uniform distribution
    ±ÕµîºÐÆ÷
  • uniform intonation method
    ±ÕµîÀ½ÆÄÁ¶»ç¹ý
  • hypothesis
    °¡¼³
  • lattice hypothesis
    °ÝÀÚ°¡¼³
  • null hypothesis
    ¿µ°¡¼³, ±Í¹«°¡¼³
  • unitarian hypothesis
    Ç×üµ¿Àϰ¡¼³
  • arterial perfusion rate
    µ¿¸Æ°ü·ùÀ²
  • attack rate
    ¹ßº´·ü
  • actual death rate
    ½ÇÁ¦»ç¸Á·ü
  • adjusted death rate
    Á¶Á¤»ç¸Á·ü
  • abortion rate
    À¯»êÀ²
  • age-specific death rate
    ¿¬·Éº°»ç¸Á·ü
  • age-specific fertility rate
    ¿¬·Éº°»ý½Ä·ü
  • age-specific rate
    ¿¬·Éº°ºñÀ²
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • hypothesis
    °¡¼³
  • null hypothesis
    ±Í¹«°¡¼³, ¿µ°¡¼³
  • rate limiting enzyme
    ¼ÓµµÁ¶ÀýÈ¿¼Ò
  • rate
    1. ¼Óµµ, 2. À², 3. Á¤µµ, 4. ¾ç
  • abortion rate
    À¯»êÀ²
  • actual death rate
    ½ÇÁ¦»ç¸Á·ü
  • adjusted death rate
    (¢¡standardized death rate) Ç¥ÁØÈ­»ç¸Á·ü
  • alveolar ventilation rate
    ÇãÆÄ²Ê¸®È¯±âÀ², ÆóÆ÷ȯ±âºñ
  • attack rate
    ¹ßº´·ü
  • basal metabolic rate
    ±âÃÊ´ë»çÀ²
  • birth rate
    Ãâ»ý·ü
  • blood flow rate
    Ç÷·ù·®, Ç÷·ù¼Óµµ
  • cardiac rate
    (¢¡heart rate) ½ÉÀå¹Úµ¿¼ö
  • case fatality rate
    Ä¡¸í·ü
  • case morbidity rate
    Áõ·ÊÀÌȯÀ²
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • uniform distribution
    ±ÕµîºÐÆ÷
  • uniform circular motion
    µî¼Ó¿ø¿îµ¿
  • uniform insonation method
    ±ÕµîÀ½ÆÄÁ¶»ç¹ý
  • blending hypothesis
    À¶ÇÕÀ¯Àü¼³
  • central plasticity hypothesis
    ÁßÃßÀ¯¿¬¼º°¡¼³
  • countercurrent hypothesis
    ¿ª·ù°¡¼³
  • drift hypothesis
    À̵¿°¡¼³
  • dual recognition hypothesis
    Ç׿øÀÌÁßÀÎÁö°¡¼³
  • estrogen window hypothesis
    ¿¡½ºÆ®·Î°Õâ°¡¼³
  • expectation hypothesis
    ¿¹Ãø°¡¼³
  • hypothesis
    °¡¼³
  • hypoxia-selectivity hypothesis
    Àú»ê¼ÒÁõ¼±Åõµ°¡¼³
  • lattice hypothesis
    °ÝÀÚ°¡¼³
  • lipid hypothesis
    ÁöÁú°¡¼³
  • metabolic hypothesis
    ´ë»ç°¡¼³
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Glucostatic hypothesis, of appetite regulation
    Ç×´ç±â¼³(ù÷ÓØÐñæò), ½Ä¿åÁ¶Àý(ãÝé¯ðàï½)
  • Lyon s hypothesis
    ¶óÀ̿°¡¼³.
  • Starling s hypothesis
    ½ºÅ¸¾Ë¸µ°¡¼³.
  • hypothesis, lattice
    °ÝÀÚ¼³
  • receptor hypothesis
    ¼ö¿ëü°¡¼³
  • BMR=£¾basal metabolic rate
    ±âÃÊ´ë»çÀ²
  • GFR => glomerular filtration rate
    »ç±¸Ã¼¿©°úÀ²
  • GFR= glomerular filtration rate
    »ç±¸Ã¼(ÞêϹô÷)°Å¸§·ü(×È).
  • GFR= glomerular filtration rate
    »ç±¸Ã¼°Å¸§·ü.
  • Heart rate
    ½É¹Ú¼ö(ãýÚÑâ¦)
  • MVR=£¾maximus voiding rate
    ÃÖ´ë¹è´¢À².
  • Westergren sedimentation rate
    ¿þ½ºÅͱ׷»Ä§°­¼Óµµ
  • absorbed dose rate
    Èí¼ö¼±·®À²
  • actual death rate
    ½ÇÁ¦»ç¸Á·ü(ËàÌ¡Ë×ËÎËô).
  • adjusted death rate
    Á¶Á¤»ç¸Á·ü.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • equivalent uniform dose
    µî°¡±ÕÁú¼±·®
  • late uniform deceleration
    Èıâµî°¨¼Ó.
  • uniform circular motion
    µî¼Ó¿ø¿îµ¿(ÔõáÜê­ê¡ÔÑ).
  • uniform distribution
    ±ÕµîºÐÆ÷(Ë»ËÄËÓ̰).
  • uniform insonation method
    ±Õµî À½ÆÄ Á¶»ç¹ý
  • uniform scale
    ±Õµî(гÔõ)´«±Ý.
  • cardiac rate =heart rate
    ½É¹Ú¼ö(¡­â¦).
  • dose rate ; dosage rate ; dose per unit time
    ¹æ»ç ÀÓº´,ÇÙÀÇ,¾à¸®¼±·®·ü, ¿ë·®.
  • atherosclerosis,monoclonal hypothesis
    ´ÜÀÏŬ·Ð¼º°¡¼³(Ó¤ìé¡­Ê£àã)
  • atherosclerosis,reaction to injury hypothesis
    ¼Õ»ó¿¡ ´ëÇÑ ¹ÝÀÀ±âÀü
  • atomic hypothesis
    ¿øÀÚ°¡¼³(ê«í­Ê£æò).
  • blending hypothesis
    À¶ÇÕÀ¯Àü¼³(¡­ë¶îîæò).
  • countercurrent hypothesis
    ¿ª·ù°¡¼³ (¡­Ê£æò).
  • cyclol hypothesis
    »çÀÌŬ·Ñ ´ÜÀ§°¡¼³(¡­Ó¤êÈÊ£æò).
  • dopamine hypothesis
    µµÆÄ¹Î °¡¼³
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • egg negative conversion rate
    Ãæ¶õÀ½ÀüÀ²
  • egg reduction rate
    Ãæ¶õ°¨¼ÒÀ²
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • basal metabolic rate
    "±â(ÃÊ,º»)´ë»çÀ²(Ðñ(õ¨,Üâ)ÓÛÞóëÒ)"
  • catalytic rate constant
    Ã˸żӵµ»ó¼ö(õºØÚáÜÓøßÈâ¦)
  • exponential growth rate constant
    Áö¼ö ¼ºÀå¼Óµµ »ó¼ö (ò¦â¦à÷íþáÜÓøßÈâ¦)
  • growth rate constant
    ¼ºÀå¼Óµµ »ó¼ö (à÷íþáÜÓøßÈâ¦)
  • rate
    À²(ëÒ)
  • rate constant
    ¼Óµµ»ó¼ö(áÜÓøßÈâ¦)
  • rate-determining step
    ¼Óµµ°áÁ¤ ´Ü°è(áÜÓøÌ½ïÒÓ«Í­)
  • rate equation
    ¼Óµµ ¹æÁ¤½Ä(áÜÓøÛ°ïïãÒ)
  • rate-limiting step
    ¼ÓµµÁ¦ÇÑ ´Ü°è(áÜÓøð¤ùÚÓ«Í­)
  • rate zonal centrifugation
    ¼Óµµ ±¸¿ª ¿ø½ÉºÐ¸®(áÜÓøÏ¡æ´êÀãýÝÂ×î)
  • mutation rate
    º¯ÀÌÀ²(ܨì¶ëÒ)
  • reaction rate
    ¹ÝÀÀ ¼Óµµ·Ð(ÚãëëáÜÓøÖå)
  • specific growth rate
    ºñ¼ºÀåÀ²(Ýïà÷íþëÒ)
  • specific rate constant
    ƯÀÌ ¼Óµµ»ó¼ö(÷åì¶áÜÓøßÈâ¦)
  • specific reaction rate
    ƯÀÌ ¹ÝÀÀ¼Óµµ(÷åì¶ÚãëëáÜÓø)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • hypothesis
    °¡¼³
  • uniform distribution
    ±ÕµîºÐÆ÷
  • uniform insonation method
    ±ÕµîÀ½ÆÄÁ¶»ç¹ý
  • basal metabolic rate
    ±âÃÊ´ë»çÀ²
  • compression rate
    ¾ÐÃàÀ²
  • dose rate
    ¼±·®·ü
  • erythrocyte sedimentation rate
    ÀûÇ÷±¸Ä§°­¼Óµµ, Ç÷ħ¼Óµµ
  • frame rate
    È­¸éÀ²
  • metabolic rate
    ´ë»çÀ²
  • molecular tumbling rate
    ºÐÀÚÅÒºí¸µÀ²
  • pulse rate
    ¸Æ¹Ú¼ö, ÆÞ½ºÀ²
  • pulse repetition rate
    ÆÞ½º¹Ýº¹À²
  • rate
    ¼Óµµ, ¾ç, À², ºñ
  • relaxation rate
    ÀÌ¿ÏÀ²
  • respiration rate
    È£Èí·ü
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
ECG Electro-Cardio-Graphy(-Gram); ½ÉÀüµµ
   = EKG
  1. Conducting System Structu...
CPR cardiopulmonary reserve; cardiopulmonary resuscitation; centripetal rub; cerebral cortex perfusion r...
CSR central supply room; chart-stimulated recall [test]; Cheyne-Stokes respiration; continued stay revie...
PR by way of the rectum [Lat. per rectum]; far point [of accommodation] [Lat. punctum remotum]; palindr...
H0 null hypothesis
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
(3)H hypothesis that
EUD Equivalent Uniform Dose
URL uniform resource locator
5c ER 5c Exceeding Rate
ASR Absolute synthesis rate
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • uniform : ´Ù¾çÇÔ, ÇüÅ¿¡ À־ÀÇ º¯È­, ¸ðµç ¹ß»ý ¶Ç´Â ¡ÈÄ¿¡ À־ÀÇ Æ¯Â¡ÀÌ ºÎÁ·ÇÑ »óÅÂ.

    uniform circular motion

    µî¼Ó ¿ø¿îµ¿
  • equivalent uniform dose
    µî°¡ ±ÕÁú ¼±·®
  • uniform distribution
    ±Õµî ºÐÆ÷
  • uniform scale
    ±Õµî ´«±Ý
  • altered-self hypothesis
    º¯È­ÇÑ ÀÚ±â Ç׿ø °¡¼³
    T-B Çùµ¿ÀÛ¿ëÀ̳ª Killer T ¼¼Æ÷ÀÇ Ç¥Àû¼¼Æ÷ÀÇ ÀÎ½Ä ±â±¸¿¡ À־ ¸²ÇÁ±¸´Â ¹ÝÀÀÇÏ´Â »ó´ëÀÇ ±¸Á¶·Î¼­ ºñÀÚ±âÀÎ Ç׿ø°ú ÀÚ±âÀÎ MHCÀÇ ¾çÂÊÀ» ÀνÄÇϰí ÀÖ´Ù. ÀÌ °æ¿ì »ý°¢ÇÏ´Â ¹æ½Ä¿¡ µÎ °³ÀÇ ¹æ½ÄÀÌ ÀÖÀ¸¸ç ºñÀÚ±â¿Í ÀڱⰡ ÇϳªÀÇ °ÍÀ¸·Î¼­ ÇÑ Á¾·ùÀÇ ¼ö¿ëü¿¡ ÀÇÇÏ¿© ÀÎ½ÄµÈ´Ù°í »ý°¢ÇÏ´Â °ÍÀÌ º¯È­ÇÑ ÀÚ°¡ Ç׿ø °¡¼³ÀÇ »ý°¢ ¹æ½ÄÀÌ´Ù.
  • convergence-projection hypothesis
    ÆøÁÖ Åõ»ç °¡¼³
  • dual recognition hypothesis
    2Áß Àνļ³
    ¸é¿ª ¼¼Æ÷ »çÀÌÀÇ »óÈ£ ÀÛ¿ë¿¡ À־ÀÇ T ¼¼Æ÷ÀÇ ÀÎ½Ä ±â±¸¿¡ °üÇÑ °¡¼³ÀÇ Çϳª. T ¼¼Æ÷¿¡´Â ÀÚ±âÀÇ MHC ºÐÀÚ¸¦ ÀνÄÇϱâ À§ÇÑ ¼ö¿ëü¿Í ´Ù¸¥ °ÍÀ» ÀνÄÇϱâ À§ÇÑ ¼ö¿ëü°¡ °¢°¢ µ¶¸³ÇÏ¿© Á¸ÀçÇÑ´Ù°í ÇÏ´Â »ý°¢.
  • hypothesis
    °¡¼³
    ¸î °¡ÁöÀÇ Çö»óÀ» ¼³¸íÇÒ ¼ö ÀÖÀ¸¸ç Ãß·ÐÀ̳ª ½ÇÇèÀ» ±âÃÊ·Î ÇÏ¿© °¡Á¤µÈ ÃßÃø.
  • Starling's hypothesis
    ½ºÅ»¸µÀÇ °¡¼³
  • unitarian hypothesis
    Ç×ü µ¿Àϼ³
  • absorptace rate
    Èí¼öÀ²
    ÀÎü¿¡ Á¶»çµÇ´Â ¹æ»ç¼±¿¡ ´ëÇØ ÀÎü¿¡ Èí¼öµÇ´Â ¹æ»ç¼± ¿¡³ÊÁöÀÇ ºñÀ².
  • absorption rate
    Èí¼öÀ²
    ÀÏÁ¤ ½Ã°£¿¡ »¡¾ÆµéÀÌ´Â ¼Óµµ¸¦ ³ªÅ¸³»´Â À².
  • adjusted death rate
    Á¶Á¤ »ç¸Á·ü
  • attack rate
    ¹ßº´·ü, ÀÌȯÀ²
  • basal metabolic rate
    ±âÃÊ ´ë»çÀ²
    ½Ä»ç ÈÄ ÀÏÁ¤ ½Ã°£ÀÌ Áö³ª°í ³ª¼­ÀÇ ¾ÈÁ¤ »óÅ¿¡¼­ÀÇ »ê¼Ò ¼Òºñ ¼Óµµ.
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
uniform rate hypothesis <biology> This states that any two evolving organismal lineages diverge from a common ancestor at a constant rate with respect to each other.
(09 Oct 1997)
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
uniform Marked by lack of variation, diversity, change in form, degree or character in all occurrences or manifestations.
(18 Nov 1997)
uniform mechanical code (UMC) A code sponsored by the International Association of Plumbing and Mechanical Officials and the International Conference of Building Officials, adopted and amended by the Oregon Department of Commerce. The UMC contains requirements for the installation and maintenance of heating, ventilating, cooling, and refrigeration systems.
(05 Dec 1998)
adaptor hypothesis A hypothesis, proposed by F.H.C. Crick, that an adaptor molecule must be present between the information-containing DNA and the protein being synthesised.
(05 Mar 2000)
altered self hypothesis The hypothesis that the T-cell receptor in MHC mediated phenomena recognises a syngeneic MHC Class I or Class II molecule after modification by a virus or certain chemicals.
See: MHC restriction.
(18 Nov 1997)
alternative hypothesis In Neyman-Pearson testing of a hypothesis, the hypothesis or family of hypotheses about the numerical value of a parameter if and only if the null hypothesis is rejected as untenable.
(05 Mar 2000)
autocrine hypothesis That tumour cells containing viral oncogenes may have encoded a growth factor, normally produced by other cell types, and thereby produce the factor autonomously, leading to uncontrolled proliferation.
(05 Mar 2000)
Avogadro's hypothesis <physics> The hypothesis that equal volumes of two different gases at the same temperature and pressure contain the same number of molecules.
(02 Jan 1998)
Bayesian hypothesis An array of surmised values of a parameter to be severally explored in the light of a current set of data, with logical symmetry being preserved among all. The merits of each hypothesis entertained are based on quantity, the prior probability. The probability of the data conditional on the hypothesis is computed as the conditional probability for each; the product of the two for each hypothesis is the joint probability, and the ratio of each joint probability to the sum of all the joint probabilities is the posterior probability for that hypothesis. Unlike the Neyman-Pearson test of hypotheses, the answer is a statement about the hypothesis, not about the sample conditional on the hypothesis. No hypothesis is preferred or prevails by default. The procedure may be applied recursively any number of times, as the data becomes available.
(05 Mar 2000)
Makeham's hypothesis A development of Gompertz' hypothesis as to the force of mortality following some mathematical law. Makeham assumed that death was the consequence of two generally coexisting causes: 1) chance; 2) a deterioration or increased inability to withstand destruction. The first of these is constant, the second is an increasing geometrical progression.
(05 Mar 2000)
gate-control hypothesis A theory to explain the mechanism of pain; small fibre afferent stimuli, particularly pain, entering the substantia gelatinosa can be modulated by large fibre afferent stimuli and descending spinal pathways so that their transmission to ascending spinal pathways is blocked (gated).
Synonym: gate-control hypothesis.
(05 Mar 2000)
Gompertz' hypothesis A theory that the force of mortality increases in geometrical progression, being based on the assumption that the average exhaustion of a person's power to avoid death is such that at the end of equal infinitely small intervals of time he loses equal proportions of the power to oppose destruction which he had at the commencement of each of these intervals.
(05 Mar 2000)
chemiosmotic hypothesis <biochemistry, cell biology> A theoretical mechanism (proposed by Mitchell) to explain energy transduction in the mitochondrion. As a general mechanism it is the coupling of one enzyme catalysed reaction to another using the transmembrane flow of an intermediate species. For example Cytochrome oxidase pumps protons across the mitochondrial inner membrane and ATP synthesis is driven by re entry of protons through the ATP synthesising protein complex. The alternative model is production of a chemical intermediate species, but no compound capable of coupling these reactions has ever been identified.
(18 Nov 1997)
Michaelis-Menten hypothesis <chemistry> That a complex is formed between an enzyme and its substrate (the O'Sullivan-Tompson hypothesis), which complex then decomposes to yield free enzyme and the reaction products (Brown hypothesis), the latter rate determining the overall rate of substrate-product conversion.
See: Michaelis-Menten constant, Michaelis-Menten equation.
(05 Mar 2000)
mnaemic hypothesis The theory that stimuli or irritants leave definite traces (engrams) on the protoplasm of the animal or plant, and when these stimuli are regularly repeated they induce a habit which persists after the stimuli cease; assuming that the germ cells share with the nerve cells in the possession of engrams, acquired habits may thus be transmitted to the descendants.
Synonym: mnaemic theory, mnemism, Semon-Hering theory.
(05 Mar 2000)
wobble hypothesis <molecular biology> Explains why the base Inosine is included in position 1 in the anticodons of various t RNAs, why many mRNA codon words translate to a single amino acid, why there are appreciably fewer t RNAs than mRNA codon types and why the redundant nature of the genetic code translates into a precise set of 20 amino acids.
Inosine in Position 1 in the anticodon can base pair with A, u or C in position 3 in the mRNA codon, so that for example UCU, UCC, UCA all code for Serine using an inosine anticodon.
(18 Nov 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • hypothesis
    °¡¼³
  • uniform
    ÇѰᰰÀº; Á¦º¹
  • dress uniform
    ¿¹º¹
  • efficient market hypothesis
    (Áõ±Ç)È¿À²Àû ½ÃÀå °¡¼³(»õ·Î¿î Á¤º¸ÀÇ ÁÖ°¡¿¡ÀÇ ¹ÝÀÀÀº µ¿½ÃÀûÀ̶õ °¡¼³)
  • hypothesis
    °¡¼³;°¡Á¤
  • nebular hypothesis(theory)
    (õ)(žç°èÀÇ)¼º¿î¼³
  • service uniform
    Æò»óº¹
  • uniform
    ÀÏÁ¤ÇÑ ÇѰᰰÀº
  • at any rate
    ÇÏ¿©Æ°
  • heart rate
    ¸Æ¹Ú
  • monthly rate
    1°³¿ù ¿ä±Ý
  • rate
    ºñÀ²,À²,(º¹¼ö)¿ä±Ý,Æò°¡ÇÏ´Ù
  • ad rate
    ±¤°í·á
  • bank rate
    ¾îÀ½ÇÒÀÎÀ²;ÀºÇàÀϺ¯
  • birth rate
    Ãâ»êÀ²
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á